(Press-News.org) Copenhagen, Denmark: Wearing a helmet can prevent brain injury and deaths in cyclists, yet many do not wear a helmet. New research presented at the European Emergency Medicine Congress today (Tuesday) suggests that this is largely due to issues of convenience and comfort. [1]
The study also suggests that more adult cyclists would wear helmets if they were encouraged and incentivised to do so, for example if they were provided with a free helmet, education, and periodic reminders.
The research was presented by Dr Steven Friedman, an emergency doctor at Toronto General Hospital and associate professor at the University of Toronto, Canada. He said: “Towns and cities need to create protected routes and infrastructure for people to get around safely on bikes. However, crashes will still occur, and helmets are important for preventing cycling-related head injuries.
“As an emergency physician, I frequently see injured adult cyclists and many of them were not wearing helmets at the time of the crash. I wanted to understand why some cyclists don’t wear helmets and to empower more cyclists to consistently wear a helmet.”
Dr Friedman carried out a review of previous research looking at non-legislative measures to get more adult cyclists to wear helmets [2]. Although the evidence he found was limited, it suggested that cyclists are more likely to use a helmet, given the right encouragement.
He then tested out a set of incentives to see if they would persuade more cyclists to wear helmets. A group of 72 injured cyclists, who had not been wearing a helmet and were treated at Toronto General Hospital, took part in the research. Their ages ranged from 18 to 68 years and there was an even split of women and men.
All participants were asked about their cycling habits. The majority said they planned to cycle on the day they were injured and that they cycled most days outside of the winter months. However, most said they never or rarely wore a helmet (76%), even though very few thought that helmets were unnecessary or ineffective, and around half believed that cycling in Toronto is dangerous.
Female cyclists were marginally more likely to report wearing a helmet most of the time or always when cycling on their own bike. Women and men gave broadly the same reasons for not wearing a helmet, with the most common being that they did not own a helmet, that it was inconvenient, or that it was uncomfortable.
Approximately one third of the injured cyclists were randomly assigned to a protocol to promote wearing a helmet with the others randomised to be controls. The protocol included: an explanation of the value of wearing a helmet given by the study research coordinator, a voucher to get a free helmet, scheduled email reminders with brief survey regarding helmet use, a social media group, and the opportunity to refer a friend for a free helmet after a year.
All participants were asked to complete questionnaires over the following 12 months to see whether or not they were using bike helmets.
Half of those given a voucher for a free cycle helmet redeemed their voucher. Although many participants were no longer responding to the questionnaires after a year, of those who did (17 out of the 72 people), 75% of cyclists given the incentives said they always wore a helmet, compared to 22% of controls.
Dr Friedman said: “This research helps us better understand who are the cyclists that end up in our emergency department and why they are not wearing helmets, and it enabled us to try a new protocol to promote sustained helmet use.
“The people we treated in this study were frequent commuter cyclists making planned trips, who generally do not regard cycling in the city as safe yet chose not to wear helmets for reasons largely related to convenience and comfort. Initiatives to increase helmet use should address these perceived barriers, and further explore cyclists’ perceptions of the risk of injury and death. The interventions we tested, which are based on principles of adult education and behavioural economics, may be effective for achieving sustained helmet use in adult cyclists. We now need larger studies to confirm our findings and refine our protocol.”
Dr Barbra Backus is chair of the EUSEM abstract selection committee. She is an emergency physician in Rotterdam, The Netherlands, and was not involved with the research. She said: “Cycling is generally very good for our health, and an increased use of bikes instead of cars helps to reduce air pollution and to tackle climate change. Safe cycling is important and depends both on crash prevention – with better cycling infrastructure – and appropriate use of helmets to minimise injuries when crashes do occur.
“This research helps us understand why cyclists don’t wear helmets and what might promote them to choose to do so. When cyclists are seen in the emergency department following a collision, that’s a unique opportunity for doctors to explain why helmets are important, and this study suggests that such an intervention may be effective. I hope that future research will verify and build on this work to help make cycling safer for everyone.”
END
Research explains why some cyclists don’t wear helmets and what might convince them to wear one
2024-10-14
ELSE PRESS RELEASES FROM THIS DATE:
Half of all patients with sepsis die within two years
2024-10-14
Copenhagen, Denmark: Half of all patients with sepsis admitted to an emergency medical department died within two years, according to Danish researchers investigating factors that could predict outcomes for these patients.
Dr Finn E. Nielsen, a senior scientist in the Department of Clinical Epidemiology at Aarhus University Hospital, Denmark, told the European Emergency Medicine Congress today (Tuesday) [1] that he and his colleagues examined deaths over a long follow-up period in a prospective study of 714 adult patients admitted to the emergency department with sepsis. Their findings ...
Native Hawaiian and Pacific Islander adults have third highest cardiovascular death rate in the U.S.
2024-10-14
Embargoed for release until 5:00 p.m. ET on Monday 14 October 2024
@Annalsofim
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent. ...
Gene therapy automatically converts omega-6 to omega-3 fatty acids in the body
2024-10-14
St. Louis, MO (October 14, 2024) According to the Centers for Disease Control, nearly 20% of children and teens are considered obese. Research shows it can have a dramatic impact on a variety of health conditions, including arthritis, heart conditions and other metabolic problems, and the American Academy of Pediatrics now recommends early and intensive treatment to combat obesity. Over the last four years, Shriners Children’s St. Louis researchers have been working to develop a new way to prevent the effects of childhood obesity.
Using gene therapy, Shriners Children’s St. Louis Director of Research Dr. Farshid Guilak and Senior Scientist Dr. Ruhang Tang ...
Mpox clinical presentation, diagnostic approaches, and treatment strategies
2024-10-14
About The Study: Mpox is a viral infection transmitted primarily through close skin to skin contact that typically causes a self-resolving illness but can result in severe illness and death in immunocompromised individuals. First-line therapy is supportive care, although patients with severe mpox infection may be treated with advanced therapeutics. Mpox vaccination is effective and, if available, should be offered to individuals at risk of exposure to mpox.
Corresponding Author: To contact the corresponding author, Jason Zucker, MD, MS, email Jz2700@cumc.columbia.edu.
To access the embargoed study: Visit our For The Media ...
Trends in oral and injectable HIV preexposure prophylaxis prescriptions in the US
2024-10-14
About The Study: Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, with generic tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) being the most frequently prescribed medication since 2021. Injectable PrEP use was low likely because of barriers such as the high cost of stocking this expensive medication in clinics.
Corresponding Author: To contact the corresponding author, Laura M. Mann, PhD, MPH, email lmann@cdc.gov.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.21493)
Editor’s ...
Information about sexual and gender minority services and policies on US hospital websites
2024-10-14
About The Study: Most U.S. hospital websites explicitly included sexual and gender minority (SGM) populations in their nondiscrimination policies, but only a quarter of adult hospitals had an SGM-friendly clinician directory and provided information about SGM-related resources or hospital-based services. Pediatric hospitals more frequently posted SGM-related information than adult hospitals. Hospitals in states with more discriminatory policies were less likely to provide SGM-related information online.
Corresponding Author: To contact the corresponding author, Alex S. Keuroghlian, MD, MPH, email akeuroghlian@mgb.org.
To ...
Study finds use of naloxone by Good Samaritans is up, but not nearly enough
2024-10-14
Study finds use of naloxone by Good Samaritans is up, but not nearly enough
Ohio State and National Registry of EMTs research highlights importance of public’s help in opioid overdose response
COLUMBUS, Ohio – Use of a lifesaving drug to reverse opioid drug overdoses is growing, but not fast enough. That’s according to new research in JAMA Network Open from The Ohio State University College of Medicine, College of Public Health and the National Registry of Emergency Medical Technicians.
In the first study of its kind, the research team looked at national use of naloxone by people without medical training to treat an opioid drug overdose.
“Naloxone ...
Risk of suicidal ideation or attempts in adolescents with obesity treated with GLP1 receptor agonists
2024-10-14
About The Study: In this study, adolescents with obesity prescribed a glucagon-like peptide 1 receptor agonists (GLP1R) had a lower incidence of suicidal ideation or attempts compared with matched patients not prescribed GLP1R who were treated with lifestyle intervention. These results suggest a favorable psychiatric safety profile of GLP1R in adolescents. The detected reduction in hazard ratios for suicidal ideation among adolescents with obesity prescribed GLP1R suggests potential avenues for future research.
Corresponding Author: To contact the corresponding author, Liya Kerem, MD, MSc, email liya.em@gmail.com.
To access the ...
SARS-CoV-2 infection and new-onset type 2 diabetes among pediatric patients
2024-10-14
About The Study: In this retrospective cohort study of children and adolescents ages 10 to 19, the risk of an incident diagnosis of type 2 diabetes was greater following a COVID-19 diagnosis than in children diagnosed with other respiratory infections. Further study is required to determine whether diabetes persists or reverses later in life.
Corresponding Author: To contact the corresponding author, Pauline Terebuh, MD, MPH, email pdt@case.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.39444)
Editor’s Note: Please see the article for additional information, ...
Recovery from COVID-19–related disruptions in cancer detection
2024-10-14
About The Study: This cross-sectional study of nationally representative registry data found that cancer incidence recovered meaningfully in 2021 following substantial disruptions in 2020. However, incidence rates need to recover further to address the substantial number of patients with undiagnosed cancer during the pandemic.
Corresponding Author: To contact the corresponding author, Uriel Kim, MD, PhD, MBA, email uxk13@case.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.39263)
Editor’s Note: Please ...